{"id":224983,"date":"2026-09-01T09:50:17","date_gmt":"2026-09-01T04:20:17","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=224983"},"modified":"2026-09-01T09:50:17","modified_gmt":"2026-09-01T04:20:17","slug":"why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/","title":{"rendered":"Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Price Hits Fresh 52-Week Low"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em>Astrazeneca Pharma India Ltd. (ASTRAZEN) share price fell to a fresh 52-week low of Rs 6,900.1 today and later stood at Rs 6,968.45, down 0.03% from the previous close. Market cap was Rs 17,426.88 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Astrazeneca Pharma India Ltd. traded at Rs 6,968.45, down 0.03% today, after hitting a fresh 52-week low of Rs 6,900.10. Market capitalisation stood at Rs 17,426.88 crore.<\/p>\n<p>Astrazeneca Pharma India Ltd. Share Price was at Rs 6,968.45 on 01 September 2026 at 9:42 AM IST, down 0.03% from the previous close of Rs 6,970.75, after the stock touched a fresh 52-week low of Rs 6,900.10. The company\u2019s market capitalisation stood at Rs 17,426.88 crore, placing it among the larger listed names in the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>For Astrazeneca Pharma India Ltd. Share Price Today, the verified data confirms the price event clearly: the stock opened at Rs 6,900.10, which was also the day\u2019s low, and then moved up to an intraday high of Rs 7,024.95 before trading near flat on the day. The supplied data confirms the 52-week low event, but it does not establish a company-specific catalyst behind the move. That is why Astrazeneca Pharma India Ltd. Stock News is attracting attention more for the chart event, valuation context and peer positioning than for any verified trigger in the data provided.<\/p>\n<p>For investors tracking Astrazeneca Pharma India Ltd. Share Price Live, the key numbers to monitor next are whether the stock continues to hold above the fresh yearly low, how its valuation compares with industry benchmarks, and whether its profitability profile continues to justify premium multiples. Univest highlights that this is a 52-week low event, not an all-time low call.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Astrazeneca_Pharma_India_Ltd_Share_Price_Today_Price_Action_Analysis\" title=\"Astrazeneca Pharma India Ltd. Share Price Today: Price Action Analysis\">Astrazeneca Pharma India Ltd. Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Fundamental_Analysis\" title=\"Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis\">Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Why_Investors_Are_Watching_Astrazeneca_Pharma_India_Ltd\" title=\"Why Investors Are Watching Astrazeneca Pharma India Ltd.\">Why Investors Are Watching Astrazeneca Pharma India Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#About_Astrazeneca_Pharma_India_Ltd\" title=\"About Astrazeneca Pharma India Ltd.\">About Astrazeneca Pharma India Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Track_Astrazeneca_Pharma_India_Ltd_Share_Price_on_Univest\" title=\"Track Astrazeneca Pharma India Ltd. Share Price on Univest\">Track Astrazeneca Pharma India Ltd. Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Why_is_Astrazeneca_Pharma_India_Ltd_Share_Price_in_focus_today\" title=\"Why is Astrazeneca Pharma India Ltd. Share Price in focus today?\">Why is Astrazeneca Pharma India Ltd. Share Price in focus today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#What_is_the_latest_Astrazeneca_Pharma_India_Ltd_Share_Price_Today\" title=\"What is the latest Astrazeneca Pharma India Ltd. Share Price Today?\">What is the latest Astrazeneca Pharma India Ltd. Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Did_Astrazeneca_Pharma_India_Ltd_hit_a_52-week_low\" title=\"Did Astrazeneca Pharma India Ltd. hit a 52-week low?\">Did Astrazeneca Pharma India Ltd. hit a 52-week low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#What_does_todays_price_action_show_for_ASTRAZEN\" title=\"What does today\u2019s price action show for ASTRAZEN?\">What does today\u2019s price action show for ASTRAZEN?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Is_Astrazeneca_Pharma_India_Ltd_expensive_compared_with_its_industry\" title=\"Is Astrazeneca Pharma India Ltd. expensive compared with its industry?\">Is Astrazeneca Pharma India Ltd. expensive compared with its industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#How_profitable_is_Astrazeneca_Pharma_India_Ltd_based_on_current_ratios\" title=\"How profitable is Astrazeneca Pharma India Ltd. based on current ratios?\">How profitable is Astrazeneca Pharma India Ltd. based on current ratios?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#How_does_Astrazeneca_Pharma_India_Ltd_compare_with_peers\" title=\"How does Astrazeneca Pharma India Ltd. compare with peers?\">How does Astrazeneca Pharma India Ltd. compare with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#What_should_investors_track_next_in_Astrazeneca_Pharma_India_Ltd_Stock_News\" title=\"What should investors track next in Astrazeneca Pharma India Ltd. Stock News?\">What should investors track next in Astrazeneca Pharma India Ltd. Stock News?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Astrazeneca_Pharma_India_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Astrazeneca Pharma India Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,968.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,970.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -2.3 (-0.03%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,900.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,024.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,900.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.03 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17,426.88 crore<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) traded at Rs 6,968.45. versus the previous close of Rs 6,970.75, a fall of 0.03%. The stock opened at Rs 6,900.1, reached Rs 7,024.95, touched Rs 6,900.1.<\/p>\n<p>Astrazeneca Pharma India Ltd. Share Price Today reflects a narrow day-on-day decline but a notable intraday test of a new one-year low, making the stock relevant in Stock Market Today and 52 Week Low Stocks discussions. The price action shows weakness at the low end of the recent range, even though the closing trade remained above the day\u2019s trough.<\/p>\n<p>The stock moved from a previous close of Rs 6,970.75 to Rs 6,968.45, a decline of Rs 2.30 or 0.03%. It opened at Rs 6,900.10, touched a high of Rs 7,024.95 and a low of Rs 6,900.10, which now stands as the fresh 52-week low. Turnover was Rs 0.03 crore. With Astrazeneca Pharma India Ltd. Market Cap at Rs 17,426.88 crore, the move was small in percentage terms but still meaningful because the stock printed a new 52-week trough.<\/p>\n<p>In Astrazeneca Pharma India Ltd. Share News and Astrazeneca Pharma India Ltd. News Today searches, that distinction matters. The day\u2019s open exactly matching the low suggests immediate pressure near the open, followed by some recovery into the session high. Available market indicators also show the stock below its 50-day moving average of Rs 7,730.23 and 200-day moving average of Rs 8,321.64, while the 14-day RSI stands at 21.48, a reading typically associated with weak momentum. That makes valuation and company financials the next logical areas to examine on Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Fundamental_Analysis\"><\/span><strong>Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17,426.88 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">102.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.27x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 67.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 361.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.52%<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) fundamental metrics show P\/E 102.74x, P\/B 19.27x, ROE 23.02%, ROCE 31.24%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Astrazeneca Pharma India Ltd. has a market capitalisation of Rs 17426.88 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 102.74x, P\/B at 19.27x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.02% and ROCE of 31.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 67.85, book value per share of Rs 361.68, dividend yield of 0.52%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 30.86x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">102.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.86x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">47.7x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.87x to 667.16x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.27x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17,426.88 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 679.12 crore<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P\/E ratio of 102.74x, which is above the benchmark median of 30.86x, a difference of +232.92%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of 23.02%, which is above the benchmark median of 11.79%, a difference of +95.25%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 31.24%, which is above the benchmark median of 13.63%, a difference of +129.2%.<\/p>\n<p>Track stocks falling to yearly lows through the <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Suven Pharmaceuticals Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">COHANCE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17,241.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">164.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.12<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Glenmark Life Sciences Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ALIVUS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17,237.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.61<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Shilpa Medicare Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SHILPAMED<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17,685.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.43<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Eris Lifesciences Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ERIS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18,252.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">27.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.59<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Alembic Pharmaceuticals Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">APLLTD<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,000.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.74<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P\/E ratio of 102.74x compared with the displayed peer median of 28.59x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 23.02% compares with a peer median of 12.35% across the companies shown in the table. ROCE stood at 31.24% versus the displayed peer median of 11.74%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 17,426.88 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Astrazeneca_Pharma_India_Ltd\"><\/span><strong>Why Investors Are Watching Astrazeneca Pharma India Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock touched a fresh 52-week low of Rs 6,900.10 even though the day\u2019s decline was only 0.03%.<\/li>\n<li>Astrazeneca Pharma India Ltd. Share Price is trading below the 50-day average of Rs 7,730.23 and the 200-day average of Rs 8,321.64.<\/li>\n<li>The 14-day RSI at 21.48 places the stock in a weak-momentum zone often tracked in Oversold Stocks and Bearish Stocks screens.<\/li>\n<li>P\/E of 102.74 and P\/B of 19.27 remain far above industry medians despite ROE of 23.02 and ROCE of 31.24.<\/li>\n<li>The company sits in the Healthcare sector with a market cap above the same-industry average, keeping it in Stocks in News and Market Movers discussions on Univest.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Astrazeneca_Pharma_India_Ltd\"><\/span><strong>About Astrazeneca Pharma India Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Astrazeneca Pharma India Ltd. is a listed Healthcare company classified under the Pharmaceuticals &amp; Drugs industry. In market terms, it is a mid-to-large listed industry participant with a market capitalisation of Rs 17,426.88 crore. The stock trades under the symbol ASTRAZEN and is part of the Indian Stock Market universe tracked across NSE and BSE-oriented investor searches.<\/p>\n<p>Based on the supplied company context, Astrazeneca Pharma India Ltd. is evaluated by investors primarily through pharmaceutical industry benchmarks such as P\/E ratio, P\/B ratio, ROE, ROCE, EPS, book value and dividend yield. Its current data profile shows strong return ratios and premium valuation multiples, which is why Astrazeneca Pharma India Ltd. Latest News and Astrazeneca Pharma India Ltd. Company News often draw attention when the share price reaches major technical or cyclical markers such as a one-year low. Univest tracks the stock as part of Healthcare sector and Pharmaceuticals &amp; Drugs industry coverage.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Astrazeneca_Pharma_India_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Astrazeneca Pharma India Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-low lists and related market analysis.<\/p>\n<p>Investors using Univest can track Astrazeneca Pharma India Ltd. Share Price through live price updates, 52-week levels, market capitalisation, fundamental ratios, peer comparison metrics and sector benchmarks. Univest also helps users follow Astrazeneca Pharma India Ltd. NSE and Astrazeneca Pharma India Ltd. BSE style search intent with structured stock analysis, historical indicators, share price updates and company-level market insights, without turning those data points into recommendations.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Astrazeneca_Pharma_India_Ltd_Share_Price_in_focus_today\"><\/span><strong>Why is Astrazeneca Pharma India Ltd. Share Price in focus today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Ltd. Share Price is in focus because the stock touched a fresh 52-week low of Rs 6,900.10 on 01 September 2026. It later traded at Rs 6,968.45, with market capitalisation at Rs 17,426.88 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_Astrazeneca_Pharma_India_Ltd_Share_Price_Today\"><\/span><strong>What is the latest Astrazeneca Pharma India Ltd. Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Ltd. Share Price Today was Rs 6,968.45 at 9:42 AM IST. The stock was down 0.03% from the previous close of Rs 6,970.75 after moving between Rs 6,900.10 and Rs 7,024.95 during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Astrazeneca_Pharma_India_Ltd_hit_a_52-week_low\"><\/span><strong>Did Astrazeneca Pharma India Ltd. hit a 52-week low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, the stock hit a fresh 52-week low of Rs 6,900.10 in today\u2019s session. That level also matched the opening price and day\u2019s low, confirming a new one-year low based on the supplied market data.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_todays_price_action_show_for_ASTRAZEN\"><\/span><strong>What does today\u2019s price action show for ASTRAZEN?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Today\u2019s price action shows early weakness followed by some recovery. ASTRAZEN opened at Rs 6,900.10, touched a high of Rs 7,024.95 and traded at Rs 6,968.45, indicating the stock moved off the fresh 52-week trough intraday.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Astrazeneca_Pharma_India_Ltd_expensive_compared_with_its_industry\"><\/span><strong>Is Astrazeneca Pharma India Ltd. expensive compared with its industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> On supplied valuation data, yes. The company\u2019s P\/E is 102.74 versus the same-industry median of 30.86 and average of 47.7, while its P\/B is 19.27 versus the median 2.88 and average 4.27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_profitable_is_Astrazeneca_Pharma_India_Ltd_based_on_current_ratios\"><\/span><strong>How profitable is Astrazeneca Pharma India Ltd. based on current ratios?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company shows strong profitability ratios in the supplied data. ROE stands at 23.02 and ROCE at 31.24, both above the same-industry medians of 11.79 and 13.63 respectively, despite the stock\u2019s recent weak performance.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Astrazeneca_Pharma_India_Ltd_compare_with_peers\"><\/span><strong>How does Astrazeneca Pharma India Ltd. compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Ltd. trades at a higher valuation than Glenmark Life Sciences, Eris Lifesciences and Alembic Pharmaceuticals on P\/E and P\/B. However, its ROE of 23.02 and ROCE of 31.24 are stronger than those peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_track_next_in_Astrazeneca_Pharma_India_Ltd_Stock_News\"><\/span><strong>What should investors track next in Astrazeneca Pharma India Ltd. Stock News?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can track whether the stock holds above the fresh 52-week low of Rs 6,900.10, how Astrazeneca Pharma India Ltd. Share Price behaves relative to moving averages, and whether premium valuation continues to align with profitability metrics.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Astrazeneca Pharma India Ltd. Share Price hits a new 52-week low at Rs 6,968.45. marking a 0.03% decline today. Market cap stands at Rs 17,426.88 crore.<\/p>\n","protected":false},"author":29,"featured_media":224981,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-224983","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["224981"],"rank_math_title":["Astrazeneca Pharma India Ltd. Share Price at 52-Week Low"],"rank_math_description":["Astrazeneca Pharma India Ltd. Share Price touched a fresh 52-week low. Check price action, fundamentals, sector valuation and peer comparison."],"rank_math_focus_keyword":["Astrazeneca Pharma India Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Share_Price_Hits_Fresh_52_Week_Low_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/224983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=224983"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/224983\/revisions"}],"predecessor-version":[{"id":224984,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/224983\/revisions\/224984"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/224981"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=224983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=224983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=224983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}